LENZ Net Income from 2010 to 2024

LENZ Stock   35.50  1.18  3.44%   
LENZ Therapeutics Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, LENZ Therapeutics Net Loss regression line of annual values had significance of  0.0001 and arithmetic mean of (32,289,630). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-124.7 M
Current Value
-118.4 M
Quarterly Volatility
49.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LENZ Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LENZ Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 48 K or Other Operating Expenses of 55.6 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0 or PTB Ratio of 0.58. LENZ financial statements analysis is a perfect complement when working with LENZ Therapeutics Valuation or Volatility modules.
  
Check out the analysis of LENZ Therapeutics Correlation against competitors.
For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.

Latest LENZ Therapeutics' Net Income Growth Pattern

Below is the plot of the Net Income of LENZ Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in LENZ Therapeutics financial statement analysis. It represents the amount of money remaining after all of LENZ Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is LENZ Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LENZ Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (124.65 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

LENZ Net Income Regression Statistics

Arithmetic Mean(32,289,630)
Coefficient Of Variation(152.20)
Mean Deviation42,907,507
Median(109,000)
Standard Deviation49,146,260
Sample Variance2415.4T
Range124.5M
R-Value(0.83)
Mean Square Error790.1T
R-Squared0.70
Significance0.0001
Slope(9,169,747)
Total Sum of Squares33815T

LENZ Net Income History

2024-118.4 M
2023-124.7 M
2022-101.1 M
2021-70.8 M
2020-68.4 M

Other Fundumenentals of LENZ Therapeutics

About LENZ Therapeutics Financial Statements

LENZ Therapeutics investors use historical fundamental indicators, such as LENZ Therapeutics' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LENZ Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-124.7 M-118.4 M
Net Loss-9.7 M-10.2 M
Net Loss(15.30)(16.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.